10-01 :: January 2010
nanotimes
25
Companies
Facts
N
ANOBIO Corporation announced compelling
preclinical data for NB-201, a nanoemulsion-ba-
sed topical lotion for the treatment of burn wounds.
In preclinical studies, NB-201 dramatically reduced
the severity of burn wound infections as well as
inflammation following thermal injuries. The research
was conducted at the University of Michigan Medical
School in Ann Arbor as a collaborative effort bet-
ween the University and NanoBio. The study results
were presented at the 2009 Interscience Conference
on Antimicrobial Agents and Chemotherapy (ICAAC)
in San Francisco, Calif. In the study, partial thickness
burn wounds in rats were inoculated with Pseudo-
monas aeruginosa bacteria, and then were treated 8
and 16 hours later with NB-201, placebo, 5% Sulfa-
mylon and a saline control. Treatment with NB-201
resulted in a one-thousand fold reduction of bacterial
growth as compared to control (p<0.001). In addi-
tion, NB-201 demonstrated a greater reduction of
bacterial counts than Sulfamylon, a common topical
antimicrobial currently used in the treatment of burn
injuries.
© NanoInk
http://www.nanobio.com
Human Inflammation Cytokine Assay pairs the power N
ANOMETRICS Incorporated (NASDAQ: NANO)
announced a follow-on order for ten of its
of DPN
®
-deposited protein arrays with a user-friend- Atlas
®
XP metrology systems, as well as industry-
ly protocol that can be conducted on the lab bench leading NanoDiffract™ software, from a leading
without any special instrumentation. DPN provides a memory customer. These systems are incremental to
biologically friendly nanoscale method of fabricating systems previously ordered and announced earlier
arrays without splashing, which can lead to increased this year. The systems are to be delivered to multiple
background noise, and without subjecting molecules factories throughout the fourth quarter of 2009 and
to sheer forces which may disrupt biological function. first quarter of 2010 in support of technology re-
Additional assays being developed for launch this tooling for next-generation DRAM and Flash manuf-
year will target proteins implicated in various disease acturing.
states and toxicological responses.

http://www.nanometrics.com

http://www.nanoink.net/nanobio